Arcus Biosciences, Inc. (RCUS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for RCUS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 220 institutions reported holding RCUS, with 122.4 million shares worth $3.8 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Gilead Sciences | 31,424,760 | $969M | UNCHANGED |
| BlackRock | 16,416,249 | $506M | INCREASED |
| Vanguard | 9,114,122 | $281M | INCREASED |
| State Street | 6,029,484 | $186M | INCREASED |
| Wellington Management | 5,895,448 | $182M | DECREASED |
Full institutional holdings, insider history, and congressional trades for Arcus Biosciences, Inc. on SentiSense.